Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
PDF) Chapter 4 CLINICAL USE OF TUMOR MARKERS
Diagnostic serum markers for cervical cancer in clinical use. | Download Table
Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers | Semantic Scholar
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research
Tumor markers - Cusabio
Diagnostic serum markers for cervical cancer in clinical use. | Download Table
Currently available and potentially useful serum markers for cervical... | Download Table
Cancers | Free Full-Text | Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer | HTML
PDF) Organ Specific Tumor Markers: What's New?
Evaluating the Value of uPAR of Serum and Tissue on Patients With Cervical Cancer
List of common serological tumor markers in clinical use that contain a... | Download Table
Clinical Utility of Tumor Markers
Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar
Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports
Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
Table III from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar
Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review | BMC Medicine | Full Text
Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy | PLOS ONE
Table II from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer
![Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7804/1/fig-1-full.png "Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer [PeerJ]")
Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer [PeerJ]
Serum Tumour Markers in Ovarian and Cervical Cancer | Semantic Scholar
